search
Back to results

Enhancement of Emmetropization in Hyperopic Infants

Primary Purpose

Hyperopia, Hypermetropia, Farsightedness

Status
Terminated
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Spectacles
Sponsored by
Ohio State University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hyperopia focused on measuring hyperopia, ocular refraction, infant, vision

Eligibility Criteria

8 Weeks - 20 Weeks (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 3 months of age (between 8 weeks and 20 weeks)at the baseline examination
  • Either gender, any ethnicity
  • Birthweight greater than 2500g
  • Normal pregnancy and delivery (including Cesarean section delivery but excluding serious complications or conditions such as eclampsia or rubella)
  • Hyperopia of +5.00D or more but less than +7.00D spherical equivalent refractive error in each eye by cycloplegic retinoscopy using cyclopentolate 1%
  • Currently under the care of a pediatrician

Exclusion Criteria:

  • Anisometropia greater than 1.00D (difference in spherical equivalent)
  • Strabismus
  • Previous history of difficulty with pupillary dilation
  • History of cardiac, liver, asthma, or other respiratory disease
  • History of ocular disease or active ocular inflammation

Sites / Locations

  • The Ohio State University College of Optometry

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

A

Arm Description

Infants will receive spectacle under-correction of their hyperopia.

Outcomes

Primary Outcome Measures

The primary outcome will be to determine if the criterion level for emmetropization (≤+3.00D by 18 months of age) is met and maintained by at least 70% of treated infants.

Secondary Outcome Measures

Full Information

First Posted
December 11, 2007
Last Updated
October 18, 2012
Sponsor
Ohio State University
Collaborators
The Ohio Lions Eye Research Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT00574717
Brief Title
Enhancement of Emmetropization in Hyperopic Infants
Official Title
Enhancement of Emmetropization in Hyperopic Infants
Study Type
Interventional

2. Study Status

Record Verification Date
October 2012
Overall Recruitment Status
Terminated
Why Stopped
Lack of funding support for continued recruitment, enrollment, treatment
Study Start Date
December 2007 (undefined)
Primary Completion Date
September 2010 (Actual)
Study Completion Date
September 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ohio State University
Collaborators
The Ohio Lions Eye Research Foundation

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
To determine if wearing a moderate spectacle under-correction (3.00D) and performing activities designed to stimulate accurate accommodation during a 15-month period will enhance emmetropization in highly hyperopic (between +5.00D and +7.00D) 3-month old infants.
Detailed Description
The purpose of the project is to determine if emmetropization can be enhanced in very farsighted babies. We will give them glasses with a partial correction, an amount that is less than their full degree of farsightedness but enough to put them in the zone of effective emmetropization. This 'boost' is meant to enable very farsighted babies to use their eyes in a normal way and emmetropize as normal infants. This partial correction would be given at 3 months of age for a period of up to 15 months. A program of visual engagement is also provided in order to encourage the normal development and use of accommodation. As changes in farsightedness occur, the power of the glasses will be reduced at follow up appointments to keep the farsightedness within the zone of effective emmetropization. Once an infant reaches a normal amount of farsightedness, the glasses would be discontinued.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hyperopia, Hypermetropia, Farsightedness
Keywords
hyperopia, ocular refraction, infant, vision

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
6 (Actual)

8. Arms, Groups, and Interventions

Arm Title
A
Arm Type
Experimental
Arm Description
Infants will receive spectacle under-correction of their hyperopia.
Intervention Type
Procedure
Intervention Name(s)
Spectacles
Other Intervention Name(s)
Under-correction
Intervention Description
Infants will receive spectacles with 3.00D of under-correction relative to the spherical equivalent in each eye as measured by the cycloplegic retinoscopy performed at baseline. They will also receive the full amount of measured astigmatism in their glasses. Changes in spectacle lens power will be made as needed at follow-up visits to keep the level of under-correction within 0.50D of the target 3.00D. A program of visual engagement is also provided to encourage the normal development and use of accommodation. Treatment will continue for 15 months (until 18 months of age) or until the infant reaches a spherical equivalent refractive error of +3.00D or less hyperopia.
Primary Outcome Measure Information:
Title
The primary outcome will be to determine if the criterion level for emmetropization (≤+3.00D by 18 months of age) is met and maintained by at least 70% of treated infants.
Time Frame
15 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
8 Weeks
Maximum Age & Unit of Time
20 Weeks
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 3 months of age (between 8 weeks and 20 weeks)at the baseline examination Either gender, any ethnicity Birthweight greater than 2500g Normal pregnancy and delivery (including Cesarean section delivery but excluding serious complications or conditions such as eclampsia or rubella) Hyperopia of +5.00D or more but less than +7.00D spherical equivalent refractive error in each eye by cycloplegic retinoscopy using cyclopentolate 1% Currently under the care of a pediatrician Exclusion Criteria: Anisometropia greater than 1.00D (difference in spherical equivalent) Strabismus Previous history of difficulty with pupillary dilation History of cardiac, liver, asthma, or other respiratory disease History of ocular disease or active ocular inflammation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Donald O. Mutti, OD, PhD
Organizational Affiliation
The Ohio State University College of Optometry
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Ohio State University College of Optometry
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43210-1240
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
11053269
Citation
Atkinson J, Anker S, Bobier W, Braddick O, Durden K, Nardini M, Watson P. Normal emmetropization in infants with spectacle correction for hyperopia. Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3726-31.
Results Reference
background
PubMed Identifier
10684846
Citation
Ingram RM, Gill LE, Lambert TW. Effect of spectacles on changes of spherical hypermetropia in infants who did, and did not, have strabismus. Br J Ophthalmol. 2000 Mar;84(3):324-6. doi: 10.1136/bjo.84.3.324.
Results Reference
background
PubMed Identifier
16123404
Citation
Mutti DO, Mitchell GL, Jones LA, Friedman NE, Frane SL, Lin WK, Moeschberger ML, Zadnik K. Axial growth and changes in lenticular and corneal power during emmetropization in infants. Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3074-80. doi: 10.1167/iovs.04-1040.
Results Reference
background
PubMed Identifier
15557849
Citation
Mutti DO, Mitchell GL, Jones LA, Friedman NE, Frane SL, Lin WK, Moeschberger ML, Zadnik K. Refractive astigmatism and the toricity of ocular components in human infants. Optom Vis Sci. 2004 Oct;81(10):753-61. doi: 10.1097/00006324-200410000-00007.
Results Reference
background
PubMed Identifier
15545141
Citation
Anker S, Atkinson J, Braddick O, Nardini M, Ehrlich D. Non-cycloplegic refractive screening can identify infants whose visual outcome at 4 years is improved by spectacle correction. Strabismus. 2004 Dec;12(4):227-45. doi: 10.1080/09273970490517935.
Results Reference
background
PubMed Identifier
7585177
Citation
Hung LF, Crawford ML, Smith EL. Spectacle lenses alter eye growth and the refractive status of young monkeys. Nat Med. 1995 Aug;1(8):761-5. doi: 10.1038/nm0895-761.
Results Reference
background
PubMed Identifier
3195068
Citation
Schaeffel F, Glasser A, Howland HC. Accommodation, refractive error and eye growth in chickens. Vision Res. 1988;28(5):639-57. doi: 10.1016/0042-6989(88)90113-7.
Results Reference
background
PubMed Identifier
10343811
Citation
Smith EL 3rd, Hung LF. The role of optical defocus in regulating refractive development in infant monkeys. Vision Res. 1999 Apr;39(8):1415-35. doi: 10.1016/s0042-6989(98)00229-6.
Results Reference
background
Links:
URL
http://optometry.osu.edu/?n=0
Description
College of Optometry Website
URL
http://optometry.osu.edu/directory/faculty_detail.cfm?id=mutti.2
Description
Principal Investigator Web Page

Learn more about this trial

Enhancement of Emmetropization in Hyperopic Infants

We'll reach out to this number within 24 hrs